Wednesday, April 17, 2024

Pfizer is sued by Texas over COVID-19 vaccine claims

Date:

Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer, alleging that the pharmaceutical company has provided misleading information regarding the effectiveness of its widely administered COVID-19 vaccine.

Warren Kenneth Paxton Jr. is an American politician and lawyer who is served as the attorney general of Texas since 2015. A member of the Republican Party, he previously served in the Texas Senate representing the eighth district and a member of the Texas House of Representatives.

Dec 1, 2023: Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine. In a complaint filed in a Lubbock County state court, Paxton said it was misleading for Pfizer to claim its vaccine was 95 percent effective because it offered a “relative risk reduction” for people who took it.

Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine.

In a complaint filed in a Lubbock County state court, Paxton said it was misleading for Pfizer to claim its vaccine was 95 percent effective because it offered a “relative risk reduction” for people who took it.

Paxton said the claim was based on only two months of clinical trial data, and vaccine recipients’ “absolute risk reduction” showed that the vaccine was just 0.85 percent effective.

He also said the pandemic got worse even after people started taking the vaccine, developed by Pfizer and its German partner BioNTech.

“Pfizer intentionally misrepresented the efficacy of its COVID-19 vaccine and censored persons who threatened to disseminate the truth in order to facilitate fast adoption of the product and expand its commercial opportunity,” the complaint said.

The lawsuit seeks to stop New York-based Pfizer from making alleged false claims and silencing “truthful speech” about its vaccine, and more than $10 million in fines for violating a Texas law protecting consumers from deceptive marketing.

Pfizer said more than 1.5 billion of people have received its vaccine. The drugmaker has reported more than $74 billion of revenue in 2021 and 2022 related to COVID-19 immunizations.

In a statement, Pfizer said its representations about its vaccine have been “accurate and science-based,” and that it believed Paxton’s lawsuit had no merit.

Pfizer also said its vaccine has “demonstrated a favorable safety profile in all age groups, and helped protect against severe COVID-19 outcomes, including hospitalization and death.”

Infectious disease experts have said relative risk reduction is a more meaningful way to judge a vaccine’s efficacy than absolute risk reduction. Relative risk shows how well a vaccine protects recipients relative to a study’s control group.

Paxton, a Republican, has criticized the Biden administration’s efforts to fight the pandemic.

Earlier this year, he began probing whether Pfizer, Moderna, and Johnson & Johnson misrepresented their vaccines’ efficacy, to examine the “scientific and ethical basis” for public health decisions addressing COVID-19.

“Pfizer did not tell the truth about their COVID-19 vaccines,” Paxton said in a statement. “We are pursuing justice for the people of Texas, many of whom were coerced by tyrannical vaccine mandates to take a defective product sold by lies.”

The lawsuit is Paxton’s second against Pfizer in November.

In a case unsealed on Nov. 21, Paxton accused Pfizer and a supplier of manipulating quality control tests, resulting in the distribution of ineffective drugs to treat attention deficit hyperactivity disorder in children.

The status of the probe into Moderna and Johnson & Johnson was not immediately clear. Paxton’s office did not immediately respond to requests for comment.

Pfizer’s Covid drug fails the test for preventing infections

Apr 30, 2022: The drug, Paxlovid, failed to meet its primary goal of significantly reducing the risk of Covid-19 infection in adults exposed to the virus through a household contact, Pfizer said in a statement Friday.

The drug, Paxlovid, failed to meet its primary goal of significantly reducing the risk of Covid-19 infection in adults exposed to the virus through a household contact, Pfizer said in a statement Friday. The drug reduced risks by about a third compared with a placebo, which didn’t meet the threshold for statistical significance.

Chief Executive Officer Albert Bourla said he was “disappointed” by the study results.

Ref: https://www.hindustantimes.com/science/pfizers-covid-drug-fails-test-for-preventing-infections-101651277281322.html

Pfizer, Dr Reddy’s among 66 firms that fail govt test for NSQ drugs

The Central Drugs Standard Control Organisation (CDSCO) has declared that 66 pharmaceutical firms have failed the test for Not of Standard Quality (NSQ) drugs. Major companies, including Zydus Healthcare, Dr Reddy’s Laboratories, Cipla, Alembic and Pfizer, are part of the list released by the government on Friday.

At least five drug samples picked up by the government failed the test, following which the companies were put on the list. The findings showed Pfizer failed the test for 25 samples, while Alembic and Dr Reddy’s Laboratories had nine NSQ quality drugs. Seven drug samples of Cipla, and six of Zydus Healthcare, too, failed the test.

Ref: https://www.business-standard.com/article/companies/pfizer-dr-reddy-s-among-66-firms-that-fail-govt-test-for-nsq-drugs-117072100646_1.html

Source: ET Pharma, Wikipedia, Facebook

Also Read:

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Medical errors and Vaccine injuries are just as deadly as any disease.

Are hospitals really as safe as we think they are? According to the World Health Organization (WHO), the...

Governor Signs Climate Engineering Ban Legislation Into Law

Tennessee Governor Bill Lee has now signed legislation into law that bans any form of climate engineering operations...

IMA vs Ramdev: Why what’s good or bad for the goose should be good or bad for the gander

Dr. (Prof) Amitav Banerjee, Epidemiologist Universal Health Organisation (UHO), Chairman Postdoctoral in epidemiology, who was a field epidemiologist for over...